Contract Win

DXS International

29/10/2024 12:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241029:nGNE7Fj42c&default-theme=true


DXS INTERNATIONAL PLC

(AQSE: DXSP)

ExpectCare First Commercial Contract

The Board of DXS International plc (“the Company” or “DXSP”), the AQSE
Growth Market quoted healthcare information and digital clinical decision
support systems provider, is pleased to announce its first NHS commercial
contract for its leading-edge AI ExpertCare Clinical Decision Support (CDS)
solution.

This unique digital solution “automates” the gathering of all
“relevant” patient and NICE treatment information to enable the
prescribing clinician to conduct all hypertension medicine reviews faster and
in accordance with NICE guidelines.

David Immelman, CEO of DXS International plc commented: “This NHS accredited
solution is one of the most cost-effective methods for minimising the public
health burden with clear measurable return on investment.”  

The Directors of DXS International plc accept responsibility for this
announcement.

Contacts:

David Immelman        01252 719800
DXS International plc
www.dxs-systems.com

AQSE Corporate Broker and Corporate Advisor
Hybridan LLP        020 3764 2341
Claire Louise Noyce

Notes to Editors

About DXS:
DXS International presents up to date treatment guidelines and
recommendations, from Clinical Commissioning Groups and other trusted NHS
sources, to doctors, nurses and pharmacists in their workflow and during the
patient consultation. This effective clinical decision support ultimately
translates to improved healthcare outcomes delivered more cost effectively and
which should significantly contribute towards the NHS achieving its projected
efficiency savings